Ribostamycin sulfate

硫酸核糖霉素

Report date: 2023/03/16 20:00:26
NME

Base Information

Drug NameRibostamycin sulfate
Drug Alias NameVistamycin
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Aminoglycoside antibiotics
Mechanisms of Action30S ribosomal subunit inhibitorsProtein biosynthesis inhibitors
Targets30S ribosomal subunit
Therapy Area/IndicationsBiliary Tract DiseasesSepsisPneumonia +[5] 
Global Approved IndicationsBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryMainland China
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesHunan Zhongnan Kelun Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsBiliary Tract DiseasesSepsisPneumonia +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeJ01GB10
Related LinksWikipediaDrugBankKEGG